Health
Nicolas Mouz - progressing towards an efficient HIV vaccine
Nicolas Mouz - progressing towards an efficient HIV vaccine European researchers have designed two new vaccine candidates to fight the HIV virus. These have been developed within the EU-funded project EURONEUT 41 .
A HIV vaccine preventing healthy cells’ infection
A HIV vaccine preventing healthy cells’ infection AIDS research has attempted many strategies to tackle the HIV virus infection. Now, a new type of vaccine developed within an EU-funded project, called EuroNeut-41 , is based on one of the envelope proteins of the HIV virus , called the gp41 protein.
New Hopes for an AIDS Vaccine
New Hopes for an AIDS Vaccine HIV is still plaguing humanity with 35 million infected people worldwide. Antiretroviral drugs do slow down the progression of the disease but at a high cost and with long term toxicity.
Air quality models: new health prevention tools
Air quality models: new health prevention tools We are all exposed to polluted air. Among main air pollutants are nitrogen oxides —the so-called ‘NOx ‘— and ozone , which cause irritation of respiratory tract and eyes, favouring cough, lung infections in children and asthma.
Laurence Rouïl - policymakers now trust air quality models
Laurence Rouïl - policymakers now trust air quality models Air quality is a public health issue. As recently as last October, the World Health Organisation classified global outdoor air pollution as ‘ carcinogenic to humans .
Page: « 3 4 5 6 7 8 9 10 11